Publikationen

2018

• 2016 Children's Tumor Foundation conference on neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis.
  Fisher MJ, Belzberg AJ, de Blank P, De Raedt T, Elefteriou F, Ferner RE, Giovannini M, Harris GJ, Kalamarides M, Karajannis MA, Kim A, Lázaro C, Le LQ, Li W, Listernick R, Martin S, Morrison H, Pasmant E, Ratner N, Schorry E, Ullrich NJ, Viskochil D, Weiss B, Widemann BC, Zhu Y, Bakker A, Serra E
  Am J Med Genet A 2018, 176(5), 1258-69
  
• Sepsis-associated encephalopathy.
  Helbing DL, Böhm L, Witte OW
  CMAJ 2018, 190(36), E1083
  
• Role of thyroid hormone in ischemic brain injury.
  Kramer F
  Dissertation 2018, Jena, Germany
  
• Heat Shock Factor 1 Epigenetically Stimulates Glutaminase-1-Dependent mTOR Activation to Promote Colorectal Carcinogenesis.
  Li J, Song P, Jiang T, Dai D, Wang H, Sun J, Zhu L, Xu W, Feng L, Shin VY, Morrison H, Wang X, Jin H
  Mol Ther 2018, 26(7), 1828-39
  
• Survivin antagonizes chemotherapy-induced cell death of colorectal cancer cells.
  Rauch A, Carlstedt A, Emmerich C, Mustafa AHM, Göder A, Knauer SK, Linnebacher M, Heinzel T, Krämer OH
  Oncotarget 2018, 9(45), 27835-50
  
• The actin binding protein Ezrin controls astrocyte functions in the healthy and injured brain.
  Schacke S
  Dissertation 2018, Jena, Germany
  
• Neuropathies in the setting of Neurofibromatosis tumor syndromes: Complexities and opportunities.
  Schulz A, Grafe P, Hagel C, Bäumer P, Morrison H, Mautner VF, Farschtschi S
  Exp Neurol 2018, 299(Pt B), 334-44
  
• Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2.
  Synodos for NF2 Consortium, Allaway R, Angus SP, Beauchamp RL, Blakeley JO, Bott M, Burns SS, Carlstedt A, Chang LS, Chen X, Clapp DW, Desouza PA, Erdin S, Fernandez-Valle C, Guinney J, Gusella JF, Haggarty SJ, Johnson GL, La Rosa S, Morrison H, Petrilli AM, Plotkin SR, Pratap A, Ramesh V, Sciaky N, Stemmer-Rachamimov A, Stuhlmiller TJ, Talkowski ME, Welling DB, Yates CW, Zawistowski JS, Zhao WN
  PLoS One 2018, 13(6), e0197350
  
• Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.
  Toledo* A, Grieger* E, Karram K, Morrison H, Baader SL
  PLoS One 2018, 13(5), e0196726 * equal contribution
  
• Induction chemoradiotherapy versus induction chemotherapy for potentially resectable stage IIIA (N2) non-small cell lung cancer: a systematic review and meta-analysis.
  Tong S, Qin Z, Wan M, Zhang L, Cui Y, Yao Y
  J Thorac Dis 2018, 10(4), 2428-36